{
 "PrintNo":"A9250","Session":2021,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2022-02-09T09:16:44.47314Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Insurance",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2022-02-09","Committee":"Insurance"}],
 "Actions":[{"Text":"REFERRED TO INSURANCE","Date":"2022-02-09","Chamber":"ASSEMBLY"}],
 "Sponsors":[{"ID":662,"Name":"John T. McDonald III","Short":"MCDONALD"},{"ID":675,"Name":"Phil Steck","Short":"STECK"}],
 "Title":"Relates to the applicability of step therapy to certain medically necessary prescription drugs",
 "Summary":"Ensures that step therapy shall not apply to medically necessary prescription drugs in the dermatologic, hematology, ophthalmologic, rheumatic, gastrointestinal, neurology, and oncology therapeutic classes, including non-formulary drugs.",
 "LawSection":"Insurance Law","LawCode":"Amd ยง4902, Ins L; amd ยง4902, Pub Health L",
 "ActClause":"AN ACT to amend the insurance law and the public health law, in relation to protecting certain therapeutic classes from step therapy",
 "SameAsPrintNo":"S8193-2021"
}